Open Access

Nutrition, metabolism and colorectal cancer

Genes & NutritionStudying the relationship between genetics and nutrition in the improvement of human health20083:80

https://doi.org/10.1007/s12263-008-0080-7

Published: 19 February 2008

Abstract

Colorectal cancer and myocardial infarction are associated at population level and in autoptic studies. Furthermore, they share many blood variables: cholesterol, triglycerides and HDL cholesterol, fructosamine, glycated haemoglobin and glycated apolipoprotein B. These blood variables are intermediates between dietary, mainly saturated fats and high glycemic index and load diets, and colorectal cancer and myocardial infarction. Blood intermediate variables can be used in dietary trials as outcomes, and even to throw light on the pathogenesis of both diseases.

Keywords

DietGlycated proteinCancerCardiovascular disease

Introduction

Mortality for colorectal cancer (CRC) and for myocardial infarction (MI) are associated at population level [39]. Correa et al. [7] found in an autopsy study on 842 autopsies, that the most extensive atherosclerotic involvement of the aorta was in subjects with adenomatous polyps of the colon, and even more in subjects with adenonomatous and hyperplastic polyps together. Furthermore, Stemmerman [35] in an autopsy study on 288 autopsies found that the degree of the atherosclerosis of the coronary arteries and aorta was positively and significantly related not only to the presence of adenomatous polyps, but also to their size, multiplicity and degree of atypia as well.

MI and CRC can share a common cause, a common intermediate factor or both. In this review we explore the possibility that MI and CRC not only share some common cause, but also some common intermediate factors.

Metabolism, myocardial infarction and colorectal cancer

It is known that MI is associated with high blood cholesterol, LDL cholesterol and triglycerides and low HDL cholesterol [22], however these associations are weaker and even uncertain in old people [29]. Furthermore, MI is associated with the metabolic syndrome and with diabetes [15].

In non-diabetic subjects, MI is associated with HbA1c [16], as well as with fructosamine, an index of glycated proteins in the blood, at least in women [4], and with glycated apolipoprotein B [28].

Several studies have evaluated the association between serum cholesterol and colorectal adenomatous polyps or carcinoma in situ [1, 2, 8, 13, 19, 20, 24, 40]. Most but not all of these studies found an association of colorectal adenoma or cancer in situ with serum cholesterol. Serum triglycerides were associated with colorectal adenoma [25, 32], and with colorectal cancer in situ [40]. CRC was found associated with the metabolic syndrome [6, 37]. CRC and adenomas are associated with diabetes or prediabetes [14, 17, 18, 21, 23, 30, 33, 38, 41]. We found that fructosamine is associated with colorectal adenoma [27], as well as glycated apolipoprotein B with colorectal adenoma and cancer (Misciagna et al., unpublished data).

Diet, myocardial infarction and colorectal cancer

The association of both MI and CRC with blood lipids and non enzymatic glycated serum proteins also in non diabetic subjects allows to study the effects of diet on MI and CRC through the effects of diet on these intermediate variables. Cholesterol, triglycerides and HDL cholesterol are influenced by both saturated fats and sugars in the diet [5, 9], glycated haemoglobin is influenced by saturated fats in the diet [3, 11, 12], fructosamine by glycemic index and load [26], as well as glycated apolipoprotein B (Misciagna et al., unpublished data). All these results show that MI and CRC are associated with a diet rich in saturated fats and at high glycemic index and load.

Conclusions

The results of many epidemiological studies show that MI and CRC share many intermediate variables: cholesterol, cholesterol HDL, triglycerides, glycated haemoglobin and apoliprotein B, fructosamine. Furthermore, using the relationship of diet with these intermediate blood variables, it is possible to deduce that dietary saturated fats, glycemic index and load are associated with CRC and MI. The discovery of blood intermediate variables between diet and MI and CRC can open the way to trials of the effects of diet on these variables, to add evidence to the results of the observational epidemiological studies on diet and cardiovascular diseases or colorectal cancer.

Myocardial infarction and colorectal cancer share some dietary causes and intermediate variables, do they share also some pathogenetic mechanisms ?

Glycated ApoB has been found in the macrophages of the arterial wall, in the fatty streaks of atherosclerotic vessels [36]. In fact, macrophages prefer glycated, oxidized or glyco-oxidized lipoproteins for their scavenger receptors, not the normal ones [34].

It is known that neoplastic cells behave like a macrophage and have a strong phagocytic activity [10, 31], so may be colorectal cancer too, like the macrophages of the arterial wall in atherosclerosis, “eats” glycated lipoprotein.

Authors’ Affiliations

(1)
Laboratory of Epidemiology, IRCCS De Bellis
(2)
Laboratory of Biochemistry, IRCCS De Bellis
(3)
University of Nevada, Health Sciences System

References

  1. Bayerdorffer E, Mannes GA, Richter WO, et al (1993) Decreased high-density lipoprotein cholesterol and increased low-density cholesterol levels in patients with colorectal adenomas. Ann Int Med 118:481–487PubMedGoogle Scholar
  2. Bird CL, Ingles SA, Frankl HD, Lee ER, Longnecker MP, Haile RW (1996) Serum lipids and adenoma of the left colon and rectum. Cancer Epidemiol Biomark Prev 5:607–612Google Scholar
  3. Boeing H, Weisgerber UM, Jeckel A, Rose HJ, Kroke A (2000) Association between glycated hemoglobin and diet and other lifestyle factors in a non diabetic population: cross-sectional evaluation of data from the Potsdam cohort of the EPIC Study. Am J Clin Nutr 71:1115–1122PubMedGoogle Scholar
  4. Browner WS, Pressman AR, Lui LY, Cummings SR (1999) Association between serum fructosamine and mortality in elderly women: the study of osteoporotic fractures. Am J Epidemiol 149:471–475PubMedGoogle Scholar
  5. Chong MF, Fielding BA, Frayn KN (2007) Metabolic interaction of dietary sugars and plasma lipids with a focus on mechanisms and de novo lipogenesis. Proc Nutr Soc 66:52–59PubMedView ArticleGoogle Scholar
  6. Colangelo LA, Gapstur SM, Gann PH, Dyer AR, Liu K (2002) Colorectal cancer mortality and factors related to the insulin resistance syndrome. Cancer Epidemiol Biomark Prev 11:385–391Google Scholar
  7. Correa P, Strong JP, Johnson WD, Pizzolato P, Haenszel W (1982) Atherosclerosis and polyps of the colon. Quantification of precursors of coronary heart disease and colon cancer. J Chronic Dis 35:313–320PubMedView ArticleGoogle Scholar
  8. Demers RY, Neale AV, Demers P, et al (1988) Serum cholesterol and colorectal polyps. J Clin Epidemiol 41:9–13PubMedView ArticleGoogle Scholar
  9. Denke MA (2006) Dietary fats, fatty acids, and their effects on lipoproteins. Curr Atheroscler Rep 8:466–471PubMedView ArticleGoogle Scholar
  10. Fais S (2007) Cannibalism: a way to feed on metastatic tumors. Cancer Lett 258:155–164PubMedView ArticleGoogle Scholar
  11. Gulliford MC, Ukoumunne OC (2001) Determinants of glycated haemoglobin in the general population: association with diet, alcohol and cigarette smoking. Eur J Clin Nutr 55:615–623PubMedView ArticleGoogle Scholar
  12. Harding AH, Sargeant LA, Welch A, et al (2001) Fat consumption and HbA1c levels. Diabetes Care 24:1911–1916PubMedView ArticleGoogle Scholar
  13. Houghton J, Lardieri GG, Zauber P, Kim KH, Cable G (2000) Effect of cholesterol levels on villous histology in colonic adenomas. Dig Dis Sci 45:896–899PubMedView ArticleGoogle Scholar
  14. Hu FB, Manson JE, Liu S, et al (1999) Prospective study of adult onset diabetes mellitus (type 2) and risk of colorectal cancer in women. J Natl Cancer Inst 91:542–547PubMedView ArticleGoogle Scholar
  15. Hu G, Qiao Q, Tuomilehto J (2005) Metabolic syndrome, diabetes, and coronary heart disease. In: Qiao Q, Tuomiletho J, Marmot M, Elliott P (eds) Coronary heart disease epidemiology. 2nd edn. Oxford University Press, New York pp 311–330Google Scholar
  16. Khaw KT, Wareham N, Bingham S, Luben R, Welch A, Day N (2004) Association of hemoglobin A1c with cardiovascular disease and mortality in adults: the European prospective investigation into cancer in Norfolk. Ann Intern Med 141:413–420PubMedGoogle Scholar
  17. Khaw KT, Wareham N, Bingham S, Luben R, Welch A, Day N (2004) Preliminary communication: glycated hemoglobin, diabetes, and incident colorectal cancer in men and women: a prospective analysis from the European prospective investigation into cancer-Norfolk study. Cancer Epidemiol Biomarkers Prev 13:915–919PubMedGoogle Scholar
  18. Kono S, Honjo S, Todoroki I, et al (1998) Glucose intolerance and adenomas of sigmoid colon in Japanese men. Cancer Causes Control 9:441–446PubMedView ArticleGoogle Scholar
  19. Kono S, Imanishi K, Shinchi K, Yanai F (1993) Serum lipids and left-sided adenomas of the large bowel: An extended study of self-defense official in Japan. Cancer Causes Control 4:117–121PubMedView ArticleGoogle Scholar
  20. Kono S, Ikeda N, Yanai F, Yamamoto M, Shigematsu T (1990) Serum lipids and colorectal adenoma among male self defence officials in northern Kyushu, Japan. Int J Epidemiol 19:274–278PubMedView ArticleGoogle Scholar
  21. La Vecchia C, Negri E, Decarli A, Franceschi S (1997) Diabetes mellitus and colorectal cancer risk. Cancer Epidemiol Biomark Prev 6:1007–1010Google Scholar
  22. Law MR, Rodgers A (2005) Lipids and cholesterol. In: Marmot M, Elliott P (eds) Coronary heart disease epidemiology. 2nd edn. Oxford University Press, New York, pp 174–186Google Scholar
  23. Levine W, Dyer AR, Shekelle RB, Schoenberger JA, Stamler J (1990) Post-load plasma glucose and cancer mortality in middle-aged men and women. 12-year follow up findings of the Chicago heart association detection project in industry. Am J Epidemiol 131:254–262PubMedGoogle Scholar
  24. Mannes GA, Maier A, Thieme C, Wiebecke B, Paumgartner G (1986) Relation between the frequency of colorectal adenoma and the serum cholesterol level. N Engl J Med 315:1634–1638PubMedView ArticleGoogle Scholar
  25. McKeown-Eyssen GE, and the Toronto Polyp Prevention Group (1996) Insulin resistance and the risk of colorectal neoplasia. Cancer Epidemiol Biomark Prev 5:235–247Google Scholar
  26. Misciagna G, De Michele G, Cisternino AM, Guerra V, Logroscino G, Freudenheim JL (2005) Dietary carbohydrates and glycated proteins in the blood in non diabetic subjects. J Am Coll Nutr 24:22–29PubMedGoogle Scholar
  27. Misciagna G, De Michele G, Guerra V, Cisternino AM, Di Leo A, Freudenheim JL, INTEROSP Group (2004) Serum fructosamine and colorectal adenomas. Eur J Epidemiol 19:425–432PubMedView ArticleGoogle Scholar
  28. Misciagna G, Logroscino G, De Michele G, Guerra V, Cisternino AM, Caruso MG, Trevisan M (2007) Glycated apolipoprotein B and myocardial infarction. Nutr Metab Cardiovasc Dis 17:6–12PubMedView ArticleGoogle Scholar
  29. Ravnskov U (2000) The cholesterol myths. New Trends Publishing, Washington DC, pp 47–95Google Scholar
  30. Sandhu MS, Luben R, Khaw KT (2001) Self reported noninsulin dependent diabetes, family history, and risk of 431 prevalent colorectal cancer: population based, cross sectional study. Gut 42:804–805Google Scholar
  31. Sato K, Tsuchihara K, Fujii S, Sugiyama M, Goya T, Atomi Y, Ueno T, Ochiai A, Esumi H (2007) Autophagy is activated in colorectal cancer cells and contributes to the tolerance to nutrient deprivation. Cancer Research 67:9677–9684PubMedView ArticleGoogle Scholar
  32. SchoenBird CL, Ingles SA, Frankl HD, Lee ER, Longnecker MP, Haile RW (1996) Serum lipids and adenoma of the left colon and rectum. Cancer Epidemiol BiomarkPrev 5:607–612Google Scholar
  33. Smith GD, Egger M, Shipley MJ, Marmot MG (1992) Postchallenge glucose concentration, impaired glucose tolerance, diabetes, and cancer mortality in men. Am J Epidemiol 136:1110–1114PubMedGoogle Scholar
  34. Steinberg D, Parthasarathy S, Carew TE, Khoo JC, Witztum JL (1989) Beyond cholesterol. Modifications of low-density lipoprotein that increase its atherogenicity. N Engl J Med 320:915–924PubMedView ArticleGoogle Scholar
  35. Stemmerman GN, Heilbrun LK, Nomura AMY, Yano K, Hayashi T (1986) Adenomatous polyps and atherosclerosis: an autopsy study of Japanese men in Hawaii. Int J Cancer 38:789–794View ArticleGoogle Scholar
  36. Stitt AW, He C, Friedman S, Scher L, Rossi P, Ong L, et al (1997) Elevated AGE-modified ApoB in sera of euglycemic, normolipidemic patients with atherosclerosis: relationship to tissue AGEs. Mol Med 3:617–627PubMedGoogle Scholar
  37. Trevisan M, Liu J, Muti P, Misciagna G, Menotti A, Fucci F, RIFLE Group (2001) Markers of insulin resistance and colorectal cancer mortality. Cancer Epidemiol Biomark Prev 10:937–941Google Scholar
  38. Will JC, Galuska DA, Vinicor F, Calle EE (1998) Colorectal cancer: another complication of diabetes mellitus? Am J Epidemiol 147:816–825PubMedGoogle Scholar
  39. Wynder EL, Shigematsu T (1967) Environmental factors of cancer of the colon and rectum. Cancer 20:1520–1561PubMedView ArticleGoogle Scholar
  40. Yamada K, Araki S, Tamura M, et al (1998) Relation of serum total cholesterol, serum triglycerides and fasting plasma glucose to colorectal carcinoma in situ. Int J Epidemiol 27:794–798PubMedView ArticleGoogle Scholar
  41. Zeliniuch-Jacquotte A, Shore RE, Riboli E (2000) Serum C peptide, insulin-like growth factor (IGF)-I, IGF-binding proteins, and colorectal cancer risk in women. J Natl Cancer Inst 92:1592–1600View ArticleGoogle Scholar

Copyright

© Springer-Verlag 2008